Latest News
American Airlines (AAL) Update Q1 Expectation, Should You Buy AAL?
Key points: Staffing issues and rising fuel prices still act as barriers to pre-pandemic revenue American estimated a revenue loss of 16% from Q119, 1% better than the guidance i
Time To Sell Biogen (BIIB) Stock? Limited Potential For Aduhelm
Key points: Biogen's revolutionary Alzheimers treatment will see limited commercial effect for now The CMS has limited the drug to individuals partaking in clinical trials
Shiba Inu Crypto Price Soared 35.21% on Robinhood Listing. Is It a Buy?
Key points: The Shiba Inu crypto price soared 35.21% after being listed on Robinhood. The move was expected since a similar listing on Binance triggered a rally. How
Honda (HMC) Go All-In on Electric, But Will The Hybrid Ever Die?
Key points: Honda step up electric mission with $64B investment in research and development Follows extension of partnership with GM to manufacture 'affordable' EVs H
Meta (FB) Begins Digging Into Metaverse With Virtual ‘Horizon Worlds’
Key points: Meta Platforms announces testing of virtual tools for the sale of digital assets and experiences The news is one of the first updates into the company's metaverse end
CarMax Stock Plunged Despite FY21 Revenues Surged 48.8% to $7.7Bn
Key points: CarMax stock fell despite the company’s revenues surging 48.8% to $7.7bn. Investors ignored the news in a classic ‘buy the rumor, sell the news' event. S
Biodesix (BDSX) Stock Soared 85.5% on $11.7M Capital Raise. What’s Next?
Key points: Biodesix stock soared 85.5% in a delayed response to recent events. The company recently raised $11.7 million to fund its future growth. Investors are bu
PolarityTE Stock, PTE, Jumps 45% Premarket – Is This The Reverse Stock Split?
Key points: PolarityTE could lose it’s NASDAQ quotation Something must be done and doing something might increase value A reverse Stock split might do it so is this the ex
First Tin, 1SN, Is This New Float Worth Looking At?
Key points: First Tin has just started trading in London Trading is thin, obviously - 5 trades in one hour this morning They’ve definitely got tin, but is it worth it?
Oriole Resources (ORR) Shares Rallied 8.6% on a £403K R&D Tax Rebate
Key points: Oriole Resources shares rallied 8.6% on a £403K rebate from HMRC. Investors cheered the news since it is an income source for Oriole. The company’s proje
Why Are RR, Rolls Royce Shares, Down 6% As Airlines Recover?
Key points: Given the revival of air travel, we’d expect Rolls-Royce to be doing well That isn’t how informed opinion has it though JPMorgan has just downgraded RR shares
Here’s Why Novacyt Shares Fell Despite Its COVID-19 Test’s Approval
Key points: Novacyt shares fell despite the UK approving its second COVID-19 test. Investors were largely unimpressed by the achievement due to various reasons. The
Why Is Easyjet, EZJ, The Least Expensive Of The London Airlines?
Key points: An analyst at HSBC calls Easyjet the cheapest of the London listed airlines The undervaluation is claimed to be about 30% The rest of the market doesn’t agree,
Is the Miami Crypto Bull Offensive? The Jury Is Still Out On That…
Key points: Is the Miami crypto bull offensive? Well, the jury is still out on that… The crypto industry is facing multiple challenges that it must overcome. So what
Here’s Why the Crypto Market Is Down Today: Will Crypto Go Back Up?
Key points: The crypto market has fallen significantly today and since April began. There are multiple factors behind the decline, which will likely persist. However
Sailpoint Technologies (SAIL) Jumps 29% on Thoma Bravo Acquisition
Key points: SAIL shares jumped 30% following $6.12B acquisition from Thoma Bravo Remote working trends and Russian cyber attacks have increased focus on cybersecurity
NIO (NIO) Tanks 9% On Covid-19 Production Halt, What’s Next?
Key points: NIO stock dropped as much as 9% this morning on news of production suspension The company also lags behind the wider Chinese EV market How will Nio stand
Veru (VERU) Rallies 30% on ‘Overwhelming’ Efficacy of Covid-19 Drug
Key points: Veru shares soared around 30% on overwhelming 'efficacy' of novel Covid-19 drug Phase 3 trial was cut short due to evident efficacy and no clear safety concerns
Nvidia (NVDA) Stock Has Fallen 13% In The Last Week, More To Come?
Key points: NVDA shares have sold off over 13% in the last week, trading down a further 4% this morning Macro concerns coupled with a reaction to the Fed are leaving tech stocks